Clinical Trials in Anyang, China
Locations / Anyang, China
Delta Trials lists 178 clinical trials conducted in Anyang, China, making it a notable site of clinical research activity. These trials addressing 170 medical conditions, reflecting the scope and diversity of clinical research in this location. Since 2020, 3 trials in this location have been terminated before reaching their primary endpoint. This dataset is refreshed continuously as trial statuses are updated on ClinicalTrials.gov, capturing longitudinal changes in the Anyang research landscape.
178
Total Trials
170
Conditions
3
Terminated since 2020
Browse by condition (170 total)
- Breast cancer 12 trialsAll Breast cancer trials
- Acute ischemic stroke 11 trialsAll Acute ischemic stroke trials
- Non-small cell lung cancer 11 trialsAll Non-small cell lung cancer trials
- Esophageal squamous cell carcinoma 8 trialsAll Esophageal squamous cell carcinoma trials
- Esophageal cancer 7 trialsAll Esophageal cancer trials
- Esophagus cancer 5 trialsAll Esophagus cancer trials
- Breast neoplasms 5 trialsAll Breast neoplasms trials
- Immunotherapy 4 trialsAll Immunotherapy trials
- Her2-positive breast cancer 4 trialsAll Her2-positive breast cancer trials
- Ischemic stroke, acute 4 trialsAll Ischemic stroke, acute trials
- All Gastroesophageal junction adenocarcinoma trials
- Advanced solid tumors 4 trialsAll Advanced solid tumors trials
- Transient ischemic attack 3 trialsAll Transient ischemic attack trials
- Atopic dermatitis 3 trialsAll Atopic dermatitis trials
- All Locally advanced or metastatic breast cancer trials
- Gastric cancer 3 trialsAll Gastric cancer trials
- Chemoradiotherapy 3 trialsAll Chemoradiotherapy trials
- Metastatic breast cancer 3 trialsAll Metastatic breast cancer trials
- Small cell lung cancer 2 trialsAll Small cell lung cancer trials
- Endovascular treatment 2 trialsAll Endovascular treatment trials